Clinical outcomes in critically ill children on extracorporeal membrane oxygenation with severe thrombocytopenia.

Introduction: As international guidelines suggest keeping the platelet count between 50 and 100 × 109 cells/L in children on extracorporeal membrane oxygenation (ECMO), platelet transfusions are administered to two-thirds of ECMO days, and up to 70% of these patients still bleed. We aim to describe...

Descripción completa

Detalles Bibliográficos
Publicado en:Perfusion Vol. 40; no. 3; pp. 590 - 599
Autores principales: Labarinas, Sonia, Norbisrath, Kalpana, Johnson, Dana, Meliones, Jon, Greenleaf, Christopher, Salazar, Jorge, Karam, Oliver
Formato: research tables/charts Journal Article
Publicado: Sage Publications, Ltd. Apr2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184006174&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 184006174
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        02676591
        31J
      jtl: Perfusion
      issn: 02676591
      maglogo: N
    pubinfo:
      dt: Apr2025
      vid: 40
      iid: 3
      pid: 33180
      pub: Sage Publications, Ltd.
      place: <Blank>
    artinfo:
      ui:
        184006174
        176620550
        184006174
        184006174
        10.1177/02676591241247981
        184006174
      ppf: 590
      ppct: 9
      formats:
      tig:
        atl: Clinical outcomes in critically ill children on extracorporeal membrane oxygenation with severe thrombocytopenia.
      aug:
        au:
          Labarinas, Sonia
          Norbisrath, Kalpana
          Johnson, Dana
          Meliones, Jon
          Greenleaf, Christopher
          Salazar, Jorge
          Karam, Oliver
        affil: Children's Heart Institute, Pediatric Cardiac Critical Care, Advanced Cardiopulmonary Therapies and Transplantation, University of Texas- Health Science Center at Houston, Houston, TX, USA
      sug:
        subj:
          Thrombocytopenia Therapy
          Severity of Illness
          Critically Ill Patients In Infancy and Childhood
          Extracorporeal Membrane Oxygenation Methods
          Treatment Outcomes
          Human
          Texas
          Male
          Female
          Infant, Newborn
          Infant
          Prospective Studies
          Comparative Studies
          Retrospective Design
          Academic Medical Centers
          Descriptive Statistics
          Confidence Intervals
          Odds Ratio
          Chi Square Test
          Mann-Whitney U Test
          Pearson's Correlation Coefficient
          Data Analysis Software
          Regression
          Platelet Count
          Platelet Transfusion
          Treatment Duration
          Hospital Mortality
          Hemorrhage
          Intensive Care Units, Pediatric
          Length of Stay
          Thrombocytopenia Epidemiology
          Extracorporeal Membrane Oxygenation Mortality
          Infant, Newborn: birth-1 month
          Infant: 1-23 months
          Male
          Female
      ab: Introduction: As international guidelines suggest keeping the platelet count between 50 and 100 × 109 cells/L in children on extracorporeal membrane oxygenation (ECMO), platelet transfusions are administered to two-thirds of ECMO days, and up to 70% of these patients still bleed. We aim to describe outcomes in critically ill children who develop severe thrombocytopenia on ECMO. Methods: Single-center retrospective study, enrolling critically ill children on ECMO admitted at Children's Memorial Hermann, TX, between 1/2018 and 12/2022, with at least one platelet count below 50 × 109 cells/L (severe thrombocytopenia). Platelet counts were measured four times a day. We report platelet transfusion, bleeding, hemolysis, and clotting events within 6 h after transfusion, as well as ECMO duration and mortality. Results: We enrolled 54 patients representing 337 ECMO days and 1190 platelet counts. Median weight was 3.7 kg and 54% were male. Severe thrombocytopenia was observed in 56% of platelet counts. Severe thrombocytopenia was not associated with bleeding in the subsequent 6 h (18% vs 20%, p =.95), but was associated with more frequent platelet transfusions (18% vs 11%, p =.001). There was no correlation between time spent with severe thrombocytopenia and the duration of ECMO (R2 = 0.03). While the time spent with severe thrombocytopenia was not associated with on-ECMO mortality rate (p =.36), there was an association with in-hospital mortality rate (p =.003). Conclusions: Our results indicate a restrictive platelet transfusion strategy is not associated with higher proportions of subsequent bleeding, duration of ECMO, or on-ECMO mortality rate. Multicenter studies are needed to evaluate further the appropriateness of this strategy.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N